About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
HISTORICAL VOLUME
Historical
Volume
Natco Pharma Ltd.
BSE Code
524816
ISIN Demat
INE987B01026
Book Value
467.76
NSE Code
NATCOPHARM
Dividend Yield %
0.64
Market Cap
169428.98
P/E
11.30
EPS
83.75
Face Value
2
Exchange :
BSE
NSE
Period From :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2026
2025
Period To :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2026
2025
Date
Open Price(Rs.)
High Price(Rs.)
Low Price(Rs.)
Close Price(Rs.)
Volume
Turnover
23-Mar-2026
964.10
965.00
924.00
927.75
45645
43019314
20-Mar-2026
941.75
973.00
941.75
957.85
54909
52813757
19-Mar-2026
956.15
969.00
932.95
937.05
43828
41847275
18-Mar-2026
944.00
977.00
944.00
957.50
47415
45640836
17-Mar-2026
949.00
955.00
926.65
943.35
21982
20682351
16-Mar-2026
951.10
984.95
932.65
946.10
93863
89311811
13-Mar-2026
1017.20
1019.80
951.35
956.55
114320
111581511
12-Mar-2026
1013.85
1023.85
996.10
1016.30
42236
42712941
11-Mar-2026
1044.95
1055.95
1010.30
1015.55
88414
90872077
10-Mar-2026
1021.95
1051.20
1014.00
1039.45
86977
90349264
09-Mar-2026
1009.60
1019.00
994.45
1002.20
70478
70845010
06-Mar-2026
1008.95
1025.00
1000.70
1019.35
58233
59292817
05-Mar-2026
953.75
1003.70
953.75
1000.70
117062
116217183
04-Mar-2026
955.05
992.00
945.00
952.80
279309
271600252
02-Mar-2026
820.35
967.25
820.35
956.40
54925
52320243
Page
1
of
1
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.